# A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)

> **NCT07646860** · PHASE2 · RECRUITING · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 6 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **BIOLOGICAL:** Sotatercept

## Key facts

- **NCT ID:** NCT07646860
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-17
- **Primary completion:** 2029-05-24
- **Final completion:** 2031-05-16
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07646860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07646860, "A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07646860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*